SCHEMBL21174246

SCHEMBL21174246

COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3OC)c2cc1OC

nearest known ligand 0.87

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 17/20 0.87
▸ BRAF P15056 2/20 0.67
▸ RAF1 P04049 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL21174119 0.99 FLT3 (0.85) FLT3BRAFRAF1
SCHEMBL20434905 0.93 FLT3 (1.00) FLT3BRAFRAF1
SCHEMBL22505687 0.85 FLT3 (0.85) FLT3
SCHEMBL22505620 0.85 FLT3 (0.69) FLT3BRAFRAF1
SCHEMBL22505622 0.85 FLT3 (0.69) FLT3BRAF
SCHEMBL13234456 0.84 RAF1 (0.69) FLT3BRAFRAF1
SCHEMBL22505578 0.83 FLT3 (0.66) FLT3BRAFRAF1
SCHEMBL19459348 0.81 BRAF (0.78) FLT3BRAF
SCHEMBL6376965 0.81 FLT3 (0.79) FLT3
SCHEMBL22505582 0.81 FLT3 (0.64) FLT3BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3513809-B9 MEDICINAL COMPOSITION COMPRISING TIVOZANIB KYOWA KIRIN CO LTD (JP) 2022-07-13 — — EP disclosed
EP-4000634-A1 MEDICINAL COMPOSITION COMPRISING TIVOZANIB Kyowa Kirin Co., Ltd. (JP) 2022-05-25 — — EP disclosed
EP-3513809-A1 MEDICINAL COMPOSITION Kyowa Hakko Kirin Co., Ltd. (JP) 2019-07-24 — — EP disclosed
Send feedback